PW
KRSA

Pandora Wealth’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Pandora Wealth’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2
Closed -$32 – 242
2025
Q2 		$32 Buy
+2
New +$6 ﹤0.01% 293

Other funds holding KRSA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Pandora Wealth's KRSA Position: Q3 2025 in Review

Pandora Wealth sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q3 2025, closing a stake of 2 shares — an estimated $32 sold.

Pandora Wealth first reported a position in KRSA in Q2 2025 and held it in 1 quarter. The position peaked at $32 in Q2 2025. 17 funds tracked by Wall St. Rank hold KRSA as of Q3 2025.

  • Pandora Wealth reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • Pandora Wealth sold 2 Korsana Biosciences, Inc. Common Stock shares in Q3 2025, an estimated $32.
  • Pandora Wealth first reported a position in Korsana Biosciences, Inc. Common Stock in Q2 2025 and held it in 1 quarter.
  • Pandora Wealth's Korsana Biosciences, Inc. Common Stock position peaked at $32 in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q3 2025.

Based on Pandora Wealth's 13F filing for Q3 2025, filed 3 Nov 2025.